Skip to main content

Glipizide

NDC 82868-025 · Northwind Health Company, LLC

Generic nameGlipizide
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GLIPIZIDE
Strength5 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

82868-025-30 — 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-30)

82868-025-90 — 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (82868-025-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-668 — Glipizide, 71610-680 — Glipizide, 72162-2102 — Glipizide, 72162-2103 — Glipizide, 72162-2215 — Glipizide, 72162-2614 — Glipizide, 72789-130 — Glipizide, 72789-463 — Glipizide, 72789-464 — Glipizide, 72789-510 — Glipizide, 72888-115 — Glipizide, 72888-116 — Glipizide, 72888-117 — Glipizide, 72888-231 — Glipizide, 80425-0437 — Glipizide, 80425-0549 — Glipizide, 82804-174 — Glipizide, 82804-959 — Glipizide, 82804-960 — Glipizide, 82868-035 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels